Steven L. McCune, MD, PhD

Northwest Georgia Oncology Centers, P.C. Marietta Cancer Center 340 Kennestone Hospital Blvd.
Suite 100
Marietta, GA 30060
Phone: (770) 281-5100
Fax: (678) 581-7105

Steven L. McCune, MD, PhD is an Atlanta native who joined the cancer care team Northwest Georgia Oncology Centers, P.C. (NGOC) in Marietta upon completion of his Fellowship at Duke University in June 2002. With a special interest in lung cancer, Dr. McCune is actively involved in cancer research and clinical trials to find a cancer cure and provide his patients with the most advanced cancer treatment available in Georgia.  He is the Director and Principal Investigator of NGOC’s William S. Gibbons Cancer Research Institute.

“The treatment options for lung cancer are rapidly evolving and expanding.  New molecular therapies are allowing us to offer leading-edge, personalized treatments to our patients to improve their  outcomes and reduce unnecessary side effects.”

Dr. McCune provides patient-centered cancer care at NGOC’s Marietta Cancer Center.

Personal DataBirthplace: Atlanta, GA
Undergraduate EducationBS, Biology, June 1987
Massachusetts Institute of Technology
Medical EducationPhD, Biochemistry
University of Alabama at Birmingham, Medical Scientist Training Program, Department of Biochemistry and Molecular Genetics
Birmingham, Alabama
June 1995

Doctor of Medicine
University of Alabama at Birmingham
Birmingham, Alabama
May 1996
Postdoctoral TrainingINTERNSHIP and RESIDENCY
Internal Medicine
University of Alabama at Birmingham, University Hospital
Birmingham, Alabama
July 1996 - June 1999

Hematology and Medical Oncology
Duke University Medical Center
Durham, North Carolina
July 1999 – June 2002
Board CertificationAmerican Board of Internal Medicine, Internal Medicine, 2001- 2011
American Board of Internal Medicine, Medical Oncology, 2003 - Present
American Board of Internal Medicine, Hematology, 2014 - Present
Association of Clinical Research Professionals, Certified Principal Investigator 2016 - Present
Medical LicensureState of Georgia, 2002 - Present (Active)
Professional SocietiesAmerican Society of Clinical Oncology
Cobb County Medical Society
Community Oncology Alliance
Georgia Society of Clinical Oncology
Medical Association of Georgia
HonorsCo-Chair, Annual Fund, Mount Paran Christian School, 2014
Board of Directors, Loving Arms Cancer Outreach, 2012 - 2014
Volunteer, North Point Community Church, 2006 - 2009
Best Graduate Student Publication Award, 1995
First Place Award, Sigma Xi Graduate Student Research Day, 1994
First Place Award, 25th Annual Medical Student Research Day, 1988
PublicationsLevasseur DN, Ryan TM, Reilly MP, McCune SL, Asakura T, Townes TM. A Recombinant Human Hemoglobin with Anti-Sickling Properties Greater Than Fetal Hemoglobin. J. Biol. Chem., 279:27518-27524, 2004.

McCune SL, Gockerman JP, Moore JO, DeCastro CM, Bass AJ, Chao NJ, Long GD, Vredenburgh JJ, Gasparetto C, Adams D, Payne N, Rizzieri DA. Alemtuzumab in Relapsed or Refractory CLL and PLL. In Press.

McCune SL, Gockerman JP, Rizzieri DA. Monoclonal Antibody Therapy in the Treatment of Non-Hodgkin Lymphoma. JAMA286: 1149-1152, 2001.

Townes TM, McCune SL. Anti-Sickling Hemoglobin U.S. Patents: 5,864,029 / 5,877,288, 1999.

Chen WY, Bailey EC, McCune SL, Dong J-Y, Townes TM. Reactivation of Silenced, Virally Transduced Genes by Inhibitors of Histone Deacetylase. Proc. Nat. Acad. Sci. USA, 94: 5798-5803,1997.

Townes TM, McCune SL. Transgenic, Cross-Linked Hemoglobin. U.S. Patents: 5,610,137 / 5,849,688, 1997.

Luhovy M, McCune SL, Dong J-Y, Prchal JF, Townes TM, Prchal JT. Stable Transduction of Recomninant Adeno-Associated Virus into Hematopoietic Stem Cells From Normal and Sickle Cell Patients. Biology of Blood and Marrow Transplantation, 2:24-30, 1996.

McCune SL, Reilly M, Chomo M, Asakura T, Townes T. Recombinant Human Hemoglobins Designed for Gene Therapy of Sickle Cell Disease. Proc. Natl. Acad. Sci. USA, 91: 9852-9856, 1994.

McCune SL, Townes TM. Retroviral Vector Sequences Inhibit Human B-Globin Gene Expressions in Transgenic Mice. Nucleic Acids Research, 22: 4477-4481, 1994.

Reilly MP, McCune SL, Ryan TM, Katsumata M, Asakura T. Preparation of Recombinant Hemoglobin in Transgenic Mice. Meth. Enzymol, 231: 403-434, 1994.

Kidd VJ, Luo W, Xiang J, Tu F, Easton J, McCune SL, Snead M. Regulated Expression of a Cell Division Controll-Related Protein Kinase During Development. Cell Growth and Differentiation, 2: 85-93, 1991.

Zinkowski RP, McCune SL, Balczon RD, Rao PN, Brinkley BR. The Centromere and Aneuploidy II: Drug-Induced Detachment and Fragmentation of Kinetochores of Mammalian Chromosomes. Prog. Clin. Biol. Res., 340B: 223-236, 1990.
Major Research InterestsClinical Trials (Oncology & Hematology)